A Randomized Placebo Controlled Clinical Trial to Determine the Impact of Digestion Resistant Starch MSPrebiotic® on Glucose, Insulin, and Insulin Resistance in Elderly and Mid-Age Adults
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Introduction: Type 2 Diabetes (T2D) has reached epidemic proportions in North America. Recent evidence suggests that prebiotics can modulate the gut microbiome, which then plays an important role in regulating lipid metabolism, blood glucose, and insulin sensitivity. As such, prebiotics are appealing potential therapeutic strategies for pre-diabetes and T2D. The key objectives of this study were to determine the tolerability as well as the glucose and insulin modulating ability of MSPrebiotic® digestion resistant starch in healthy middle aged and elderly adults. Materials and Methods: This was a prospective, blinded, placebo controlled study. Pre-diabetes and diabetes were among the exclusion factors. Elderly (>70 years) and mid-age (30 to 50 years) Canadian adults were recruited and, after 2 weeks of consuming placebo, they were randomized to consume 30 grams of either MSPrebiotic® or placebo per day for 12 weeks. In total, 42 elderly and 42 mid-age participants completed the study. Blood samples were collected over the 14 week study and analyzed for glucose, lipid profile, and CRP, lipid particles, TNF-α, IL-10, insulin and insulin resistance. Results: At baseline, the elderly population had a significantly higher percentage (p <0.01) with elevated glucose and significantly higher TNF-α (p < 0.01) compared to mid-age adults. MSPrebiotic® digestion resistant starch was well tolerated in both mid-age and elderly adults. There was a significant difference over time in blood glucose (p = 0.0301) and insulin levels (p = 0.009), as well as insulin resistance (HOMA-IR; p = 0.009) in elderly adults who consumed MSPrebiotic® compared to placebo. No significant changes were found in mid-age adults. Conclusions: Our results suggest that dietary supplementation with prebiotics such as MSPrebiotic® may be part of an effective strategy to reduce insulin resistance, a major risk factor for developing T2D, in the elderly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Desai, M. S., Seekatz, A. M., Koropatkin, N. M., Kamada, N., Hickey, C. A., Wolter, M., Pudlo, N. A., Kitamoto, S., Terrapon, N., Muller, A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.043 · Cited by 2,805 · cited 2×
“This suggests that the colonocyte apoptosis or reduced mucus production (36, 44) leading to increased bowel permeability (thought to be the basis of increased inflammatory response) could be irreversible or take longer than the 3-month period evaluated in our study.”
Fiber and prebiotics: Mechanisms and health benefits
Slavin, J. (2013) · Nutrients · doi:10.3390/nu5041417 · Cited by 2,340 · cited 1×
“Although many regulatory bodies around the world recognize the value of adequate dietary fiber, there are no dietary recommendations specifically for prebiotic consumption (7).”
The gut microbiota and host health: a new clinical frontier
Marchesi, J. R., Adams, D. H., Fava, F., Hermes, G. D. A., Hirschfield, G. M., Hold, G., Quraishi, M. N., Kinross, J., Smidt, H., Tuohy, K. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309990 · Cited by 2,302
Towards a more comprehensive concept for prebiotics
Bindels, L. B., Delzenne, N. M., Cani, P. D., & Walter, J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.47 · Cited by 914 · cited 1×
“(12) have highlighted the value of fermentation metabolites as markers for prebiotic health benefits.”
Towards microbial fermentation metabolites as markers for health benefits of prebiotics
Verbeke, K. A., Boobis, A. R., Chiodini, A., Edwards, C. A., Franck, A., Kleerebezem, M., Nauta, A., Raes, J., van Tol, E. A. F., & Tuohy, K. M. (2015) · Nutrition Research Reviews · doi:10.1017/s0954422415000037 · Cited by 343
Role of resistant starch in improving gut health, adiposity, and insulin resistance
Keenan, M. J., Zhou, J., Hegsted, M., Pelkman, C., Durham, H. A., Coulon, D. B., & Martin, R. J. (2015) · Advances in Nutrition · doi:10.3945/an.114.007419 · Cited by 243 · cited 4×
“In healthy people, this should not be surprising, given that the body will adapt by generating glucose via gluconeogenesis to prevent hypoglycemia in those with proper glycemic control (11).”
InfluentialCausality of small and large intestinal microbiota in weight regulation and insulin resistance
Scheithauer, T. P. M., Dallinga-Thie, G. M., de Vos, W. M., Nieuwdorp, M., & van Raalte, D. H. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.002 · Cited by 188 · cited 11×
“Future studies in subjects with prediabetes and T2D are warranted given that dietary supplementation is an understudied avenue for the amelioration of risk factors linked to the development and progression of these conditions.”
InfluentialAlfa, M. J., Strang, D., Tappia, P. S., Graham, M., Van Domselaar, G., Forbes, J. D., Laminman, V., Olson, N., DeGagne, P., Bray, D., et al. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2017.03.025 · Cited by 149
Self-citationInflammation meets metabolic disease: Gut feeling mediated by GLP-1
Zietek, T., & Rath, E. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00154 · Cited by 131 · cited 1×
“org January 2018 | Volume 4 | Article 260 to the improved glycemic response, which is consistent with recent publications (13, 23, 33).”
Cited by
The gut microbiome as a modulator of healthy ageing
Ghosh, T. S., Shanahan, F., & O’Toole, P. W. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00605-x · Cited by 817
Health Benefits of Resistant Starch: A Review of the Literature
Bojarczuk, A., Skąpska, S., Mousavi Khaneghah, A., & Marszałek, K. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105094 · Cited by 372
Treatment strategies against diabetes: Success so far and challenges ahead.
Khursheed, R., Singh, S. K., Wadhwa, S., Kapoor, B., Gulati, M., Kumar, R., Ramanunny, A. K., Awasthi, A., & Dua, K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172625 · Cited by 239
Chan, D. G., Ventura, K., Villeneuve, A., Du Bois, P., & Holahan, M. R. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223461 · Cited by 24
Metadata
- Authors
- Alfa, M. J., Strang, D., Tappia, P. S., Olson, N., DeGagne, P., Bray, D., Murray, B.-L., & Hiebert, B.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2018-01-22
- Volume
- 4
- Pages
- 260-260
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W2791032754
- Cited by
- 46
- References
- 9
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.